JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

Search

Cytek Biosciences Inc

Fechado

SetorSaúde

4.46 -0.89

Visão Geral

Variação de preço das ações

24h

Atual

Mín

4.35

Máximo

4.49

Indicadores-chave

By Trading Economics

Rendimento

105K

-5.5M

Vendas

6.7M

52M

EPS

-0

Margem de lucro

-10.476

Funcionários

692

EBITDA

6.4M

-4.2M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+37.11% upside

Dividendos

By Dow Jones

Próximos Ganhos

26 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

159M

660M

Abertura anterior

5.35

Fecho anterior

4.46

Sentimento de Notícias

By Acuity

17%

83%

20 / 352 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bullish Evidence

Cytek Biosciences Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

6 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

6 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

6 de fev. de 2026, 21:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Verizon Insiders Rarely Sell Company Stock. This Insider Just Did. -- Barrons.com

6 de fev. de 2026, 21:22 UTC

Conversa de Mercado

Mexico's Inflation Seen Accelerating in January -- Market Talk

6 de fev. de 2026, 21:17 UTC

Ganhos

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

6 de fev. de 2026, 21:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

6 de fev. de 2026, 21:14 UTC

Aquisições, Fusões, Aquisições de Empresas

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- Update

6 de fev. de 2026, 21:13 UTC

Ganhos

How the Software Panic Hit BDC Stocks -- and Why Some Might Be Worth Buying -- Barrons.com

6 de fev. de 2026, 21:13 UTC

Ganhos

Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers -- Barrons.com

6 de fev. de 2026, 21:04 UTC

Conversa de Mercado

Gold Closes Out Volatile Week on Higher Note -- Market Talk

6 de fev. de 2026, 20:34 UTC

Ganhos

Tech Had an Awful Earnings Season. Other Stocks Are Saving the Day. -- Barrons.com

6 de fev. de 2026, 20:27 UTC

Ganhos

These Stocks Are Today's Movers: Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More -- Barrons.com

6 de fev. de 2026, 20:24 UTC

Conversa de Mercado

Oil Futures Settle Higher As U.S.-Iran Talks Get Under Way -- Market Talk

6 de fev. de 2026, 20:20 UTC

Conversa de Mercado

U.S. Natural Gas Futures Retreat Ahead of Weekend -- Market Talk

6 de fev. de 2026, 19:48 UTC

Ganhos

Take-Two, Mondelez Get Analyst Attention -- Barrons.com

6 de fev. de 2026, 19:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- WSJ

6 de fev. de 2026, 19:30 UTC

Aquisições, Fusões, Aquisições de Empresas

Justice Department Asking Industry How Netflix or Paramount Deal for Warner Bros. Might Impact Competition, According to Subpoena -- WSJ

6 de fev. de 2026, 19:30 UTC

Aquisições, Fusões, Aquisições de Empresas

DOJ Asking if Netflix Engaged in 'Exclusionary Conduct' That May Lead to Monopoly, According to Subpoena -- WSJ

6 de fev. de 2026, 19:17 UTC

Conversa de Mercado

USDA Says Farm Income to Decrease in 2026 -- Market Talk

6 de fev. de 2026, 18:50 UTC

Ganhos

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

6 de fev. de 2026, 18:47 UTC

Conversa de Mercado

Natural Gas-Infrastructure Operators Take 'Flight to Scale' -- Market Talk

6 de fev. de 2026, 18:34 UTC

Conversa de Mercado

U.S. Oil Rig Count Rises By 1 to 412 -- Market Talk

6 de fev. de 2026, 17:58 UTC

Ganhos

Reddit Stock Falls After Strong Earnings. Wall Street Is Debating What's Next. -- Barrons.com

6 de fev. de 2026, 17:52 UTC

Conversa de Mercado
Ganhos

Global Equities Roundup: Market Talk

6 de fev. de 2026, 17:52 UTC

Conversa de Mercado
Ganhos

Amazon's CapEx Seen as Misunderstood by Investors -- Market Talk

6 de fev. de 2026, 17:20 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

6 de fev. de 2026, 17:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

6 de fev. de 2026, 17:20 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

6 de fev. de 2026, 17:18 UTC

Conversa de Mercado

Canada's Bizarre Jobs Report Points to Growing Labor Slack -- Market Talk

6 de fev. de 2026, 17:09 UTC

Conversa de Mercado

Dollar on Path to Snap Weekly Losing Streak -- Market Talk

Comparação entre Pares

Variação de preço

Cytek Biosciences Inc Previsão

Preço-alvo

By TipRanks

37.11% parte superior

Previsão para 12 meses

Média 6.17 USD  37.11%

Máximo 7.5 USD

Mínimo 5 USD

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para Cytek Biosciences Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

3 ratings

1

Comprar

2

Manter

0

Vender

Pontuação Técnica

By Trading Central

3.7 / 3.8Suporte e Resistência

Curto Prazo

Weak Bullish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

20 / 352 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Cytek Biosciences Inc

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
help-icon Live chat